GovChime
Notice ID: 06e1d16b598749398b2f5a5fd1f6054cAward NoticeAwarded

88--AAV AQP1 Study Prevention of radiation induced xerostomia in minipigs by administering AAVAQP1

Awarded on March 27, 2023. Full description on SAM.gov.

Awarded tounder 75N92023P00144 (source: SAM.gov award notice)• $360.5K

Overview

Posted
March 29, 2023
Notice type
Award Notice
NAICS
541940: Veterinary Services
Agency
Department of Health and Human Services

Notice details

Last updated
Dec 4, 2025
Award date
Mar 27, 2023
Award amount (SAM.gov award notice)
$360.5K

Identifiers

Solicitation number
75N92023R0178
Notice ID
06e1d16b598749398b2f5a5fd1f6054c
Award number (PIID)
75N92023P00144

Description

AAV AQP1 Study Prevention of radiation induced xerostomia in minipigs by administering AAVAQP1

Full description on SAM.gov

Award Overview

Award Number

75N92023P00144

Award Amount (SAM.gov award notice)

$360.5K

Award Date

Mar 27, 2023

Awardee

Awardee UEI

GNJ7BBP73WE9

Awardee CAGE Code

03399

Original Solicitation

Notice ID: 06e1d16b598749398b2f5a5fd1f6054c

Posted Date: Mar 29, 2023

Original Response Deadline: Not specified

Contacts

Documents

No documents available.

Lifecycle

Solicitation:75N92023R0178
  1. Combined Synopsis
  2. Awarded

This opportunity has been awarded.

  1. Combined SynopsisMar 13, 2023

    AAV AQP1 Study Prevention of radiation induced xer

    Notice ed4a419d00de4e9591bd23e88d99854f on SAM.gov

  2. AwardedCurrentMar 29, 2023

    88--AAV AQP1 Study Prevention of radiation induced xerostomia in minipigs by administering AAVAQP1

    Notice 06e1d16b598749398b2f5a5fd1f6054c on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
Amendment 01 The purpose of this amendment # 01 is to clarify the RFQ requirements by responding to questions submitted and also to add IT applicable clauses into the solicitation. Unless specifically noted, all other terms remain unchanged. Note: The Offeror should acknowledge on the cover page or first pages on its Quote receipt of this amendment. Please see the attached Amendment 01_SMART for more details. Title: SMART IRB Governance, Administration, and Operations Support (GAOS) This is a combined synopsis/solicitation for commercial items/services prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) FAR Subpart 13.5—Simplified Procedures for Certain Commercial Items; and FAR Part 12— Acquisition of Commercial Items; and is expected to exceed the simplified acquisition threshold. Introduction and Background Objectives The National Center for Translational Sciences (NCATS) requires a partner to facilitate user administration, process/workflow improvements, content development/moderation, requirements gathering, and dissemination of the SMART IRB (Streamlined, Multisite, Accelerated Resources for Trials Institutional Review Board) portfolio of services. SMART IRB relies on three systems: (1) the SMARTIRB.org website which is used for content distribution, notification, and educational purposes, (2) Joinder, through which institutions enter institutional information and sign the SMART IRB Authorization Agreement (AA), and (3) the Online Reliance System (ORS), through which Institutional Review Board (IRB) reliance arrangements under the SMART IRB Agreement are documented on a study-by-study basis. The selected partner will provide support in accordance with this SOW to aid in the facilitation and growth of SMART IRB. Please see the attached RFQ 75N98026Q00287 for more details
-Combined Synopsis11/13/2026
SOURCES SOUGHT NOTICE NIH SCIENTIFIC & TECHNICAL EXPERTISE ACQUISITION & MANAGEMENT (STEAM) Sources Sought Reference Number: 75N98027R00012 Proposed NAICS Code and Size Standard: 541990 — All Other Professional, Scientific and Technical Services; $19.5 million in average annual receipts Sources Sought Notice Information Introduction This is a Small Business Sources Sought notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding: (1) the availability and capability of qualified small business sources; (2) their small business and applicable socioeconomic status, including HUBZone, service-disabled veteran-owned, veteran-owned, 8(a), woman-owned, and small disadvantaged business status; and (3) their size classification relative to the proposed North American Industry Classification System (NAICS) code. Responses will assist the Government in determining the appropriate acquisition method, including whether a full or partial small business set-aside is appropriate. Interested small businesses may respond for Task Area A (Professional Services), Task Area B (Highly Specialized Scientific Services), or both. Respondents should identify their ability to perform as a prime contractor, joint venture, or subcontracting team, distinguish their own capability from that of team members, and identify limitations within each task area addressed. NIH will assess capability separately for each area. To be considered capable of supporting a task area, respondents must demonstrate that their proposed performance arrangement meets the full capability requirements stated for that task area below. Capability in both areas is not required to respond. Partial capability is insufficient to be considered capable of supporting the full task area. The Government has not made a final set-aside determination. Background The National Institutes of Health (NIH) conducts and supports biomedical and behavioral research to advance scientific knowledge and improve health. NIH requires professional, scientific, and technical contractor support for current and emerging research priorities, ongoing research activities, and related program operations. Changes in research programs and scientific methods create a continuing need for flexible service delivery and specialized expertise. Scientific & Technical Expertise Acquisition & Management (STEAM) will acquire contractor-provided services and expertise to accomplish varied project-based requirements across NIH. Individual task orders will define project objectives, tasks, deliverables or milestones, performance periods, required expertise, and resource needs. Contractors must furnish and manage the resources needed to perform multiple concurrent projects at substantial volume and adjust those resources as authorized project requirements change. NIH anticipates using cost-reimbursement contracting approximately 20 percent of the time. The actual mix will depend on individual requirements. Firms should describe their experience and ability to support this component, including any preparation needed. Existing cost-reimbursement capability or a prior Government accounting-system approval is not a mandatory condition of responding to this notice. Applicable requirements, including accounting-system adequacy, would need to be satisfied before award of a cost-reimbursement order. Purpose and Objectives The purpose of STEAM is to provide professional, scientific, and technical support for NIH research and related activities. Support includes basic, translational, and clinical research; vaccine research; general and specialized laboratory research; veterinary and animal research support; bioinformatics; computational biology; and related professional and technical services. The contractor will furnish and manage qualified resources to accomplish each statement of work (SOW), including responsibility for recruiting, verifying qualifications, retaining its personnel, and maintaining continuity of performance. Services will be furnished under individual funded, project-based task orders. The contractor will furnish resources, including personnel with expertise corresponding to the applicable labor categories, to accomplish the SOW and deliver the required project outcomes and milestones. The contractor will retain responsibility for employing, supervising, and managing its personnel. Services will not include inherently governmental functions or unauthorized personal services. Each task order will identify the applicable task area, project scope, qualifications, location, performance schedule, and security and safety requirements. Project Requirements Services may involve expertise in microbiology, molecular biology, biochemistry, infectious diseases, immunology, clinical research, bioinformatics, genomic sequencing, proteomics, image analysis, computational and systems biology, and scientific data analysis. Related requirements may include clinical trials support, laboratory operations, veterinary services, program management, and other professional or technical support within the authorized scope. Qualifications range from positions without a degree requirement to licensed practitioners and highly specialized doctoral-level professionals. The contractor must be able to furnish qualified resources within the task area or areas addressed and manage a substantial volume of concurrent project requirements. Primary anticipated locations include Bethesda and Rockville, Maryland; other locations in the Washington, DC metropolitan area; and Hamilton, Montana. Other domestic locations, overseas support, travel, or remote work may be authorized by individual orders. NIH-wide demand for task orders and contractor support fluctuates across projects, locations, and time. This notice does not provide a fixed annual volume estimate or guarantee a minimum workload. Routine task orders will establish mobilization, onboarding, and performance start schedules. Under certain circumstances, an urgent or unforeseen NIH need may require the contractor to begin authorized performance within 48 hours. For an expedited request, NIH will identify the applicable timeframe and the event from which it is measured. Respondents should describe their ability to accommodate these requests, identify the categories and locations they could support, and explain any limitations or prerequisites. Contractors must ensure that their personnel have the qualifications and relevant experience required for the assigned work and complete applicable training, competency verification, occupational health requirements, and facility-specific access approvals before beginning restricted work. For assignments involving regulated select agents or toxins, applicable individual access approvals, security risk assessments, and required training must be completed before access. Prior experience at another laboratory does not establish authorization at the receiving NIH facility. An expedited task-order request does not waive these prerequisites. The following 156 labor-category families are organized into two task areas. Each family appears once. Categories encompass applicable levels and specialties; task orders will specify required duties and qualifications. Numbered levels are not automatically equivalent to Junior, Mid-Level, or Senior designations. The task-area structure supports market research and does not establish the final award structure. Task Area A — Professional Services This area covers general professional, management, administrative, business, IT, and technical support for NIH projects, including project coordination, financial analysis, enterprise systems, and related operational services. Scientific versions of otherwise general roles are assigned to Task Area B. To be considered capable of supporting Task Area A, respondents must demonstrate the ability to fill every labor category identified under this task area with personnel who meet the applicable role-specific qualifications. Responses must address capability across all labor categories and identify any limitations. Capability in only a subset of the identified labor categories is insufficient to be considered capable of supporting Task Area A. Accessibility Specialist Accounting Technician Administration Administrative Support Administrative Support Assistant (Administrative Support) Advisor Agile Consultant Analytics Specialist BMC Administrator BMC Remedy Administrator Budget Analyst Business Process Consultant Business Systems Analyst Communications Specialist Computer Systems Analyst Consultant (Professional) Data Analyst Data Architect Database Administrator Database Analyst/Programmer Editor Engineer (Professional) Executive Consultant Facilities Management Assistant Facilities Planning Manager Facility Support Specialist Financial Analyst Grants Management Executive Graphics Designer/Web Developer Help Desk Manager Help Desk Specialist Help Desk Support Tier IT Data Scientist IT SME Management Analyst Office Manager Paralegal Payroll Support Policy Analyst Procurement Technician Program Analyst Program Assistant Program Manager Program Support Project Coordinator Project Manager Project Support Property Technician QA/QC Records Specialist SharePoint Administrator SharePoint Developer Shipping and Receiving Clerk Software Architect Software Developer Software Engineer Space Management Specialist Subject Matter Expert Systems Engineer Technical Writer Technician Web Designer Web Developer Task Area B — Highly Specialized Scientific Services This area covers scientific research and development, specialized scientific computing and analysis, laboratory services, and all clinical and animal-care roles, including associated routine support. Assignments may support basic, translational, or clinical research and specialized containment environments. Qualification requirements vary by role; not every category requires a doctoral degree or BSL-3 experience. Task Area B may include support for Biosafety Level (BSL) 1, 2, 3, and 4 laboratories and Animal Biosafety Level (ABSL) 1, 2, 3, and 4 environments, as specified in individual task orders. Support for BSL-3 and BSL-4 laboratories remains a significant specialized requirement. To be considered capable of supporting Task Area B, respondents must demonstrate the ability to fill every labor category identified under this task area with personnel who meet the applicable role-specific qualifications and to support all BSL and ABSL levels identified above. Responses must address capability across all labor categories and containment levels and identify any limitations. Capability in only a subset of the identified labor categories or containment levels is insufficient to be considered capable of supporting Task Area B. Animal Biologist Animal Technician Behavioral Geneticist Biochemist Bioinformatician Bioinformatics Scientist Biological Scientist Biologist Biologist/Microbiologist Bioprocess Engineer Biostatistician Biostatistician/Statistical Programmer Chemical Engineer Cheminformatics Scientist Chemist Chemist/Biochemist Clinical Advisor (Scientific) Clinical Biostatistician Clinical Informatics Project Manager Clinical Operations Manager Clinical Program Manager Clinical Protocol Coordinator Clinical Psychologist Clinical Research Associate Clinical Research Coordinator Clinical Research Pharmacist Clinical Research Support Clinical Social Worker Clinical Trials Admin Cognitive Neuroscientist Computer Scientist Consultant (Scientific) Cytogenetic Technologist Data Manager Data Scientist Echo Technologist Engineer (Scientific) Enzymologist Epidemiologist Genetic Counselor Imaging Specialist Immunologist Laboratory Animal Technician Laboratory Assistant Laboratory Manager Laboratory Operations Specialist Laboratory Technician Medical Assistant Medical Illustrator Medical Officer Medical Records Specialist Medical Records Technician Molecular Geneticist MRI Data Analyst MRI Psychology Researcher MRI Technologist Neurodiagnostic Technologist Nurse (Certified Nursing Assistant) Nurse (Licensed Practical Nurse) Nurse (Registered Nurse Research) Nurse (Registered Nurse) Nurse Practitioner Patient Care Coordinator Patient Coordinator Peer Review Specialist Pharmacologist Pharmacy Technician Specialist Phlebotomist Physician Assistant Physician Policy Researcher Quality Assurance Quality Assurance Analyst Quality Assurance Specialist Recruitment and Outreach Specialist Regulatory Affairs Specialist Research Analyst Research Associate Research Nurse Research Specialist Researcher Robotics Engineer Science Writer/Editor Scientific Data Manager Scientific Data Specialist Scientific Policy Analyst Scientific Program Analyst Scientific Program Manager Scientific Researcher Scientific Review Officer Scientist Statistician Technical Writer, Scientific Veterinarian Anticipated Period of Performance NIH anticipates a five-year ordering period, from April 2027 through April 2032, subject to final acquisition strategy. Individual orders will establish their own authorized performance periods. Planning estimates do not guarantee quantities, orders, or a share of work. Capability Statement/Information Sought Submit a separate, clearly labeled capability statement for Task Area A, Task Area B, or each area if responding to both. Each statement must address capability across every labor category identified within the task area addressed. A Task Area B statement must also address capability across BSL-1 through BSL-4 and ABSL-1 through ABSL-4. Each statement should describe the project-based services and labor categories supported, contractor personnel expertise and availability, current capacity, comparable project experience, management capability, and customer references. Identify unsupported categories, unsupported containment levels, and other limitations, as applicable. Disclosure of a limitation does not waive the full capability requirements stated for the applicable task area. Responses should address the following for each task area selected: (1) Experience managing comparable project-based service contracts and task orders, including the number and type of personnel supported, peak active headcount, concurrent orders or projects, locations, and volume of personnel mobilized to perform the work. Provide up to three relevant examples per task area from the last five years, including ongoing work, and identify the performing entity, customer, period, and reference contact. Federal, commercial, and academic examples may be used. If comparable experience is unavailable, identify other evidence supporting the proposed capability. Apply the recruitment questions below to the task area addressed; scientific recruiting is relevant to scientific assignments. Describe recruitment as the contractor’s responsibility for furnishing resources to perform the SOW. For a response covering both areas, distinguish capacity and lead times by area. (2) The approach to scientific recruiting, qualification and credential verification, retention, replacement of contractor personnel, expansion of project teams during surges, and geographically dispersed workforce management. Provide normal mobilization and personnel replacement timeframes. Separately describe the ability to begin authorized performance in response to urgent requests within 48 hours, with examples where available and an explanation of any Government or facility approvals affecting the start date. Do not assume that all categories or sites require continuous 48-hour response capability. The containment-specific information below applies to all respondents addressing Task Area B. For each BSL-1 through BSL-4 and ABSL-1 through ABSL-4 level, identify relevant contract performance experience, specialties, annual capacity to mobilize contractor personnel, maximum concurrent contractor personnel assignments, normal recruitment timeframes, and limitations. Distinguish company capability from proposed team-member capability and demonstrated experience from projected capacity. Identify unsupported levels; experience at one level does not establish readiness for another. If comparable experience at a level is unavailable, identify other evidence supporting the proposed capability at that level. Cross-reference item (7) without double counting capacity across levels. Support for all identified levels is required to be considered capable of supporting Task Area B. Item (3) places particular emphasis on BSL-3, BSL-4, ABSL-3, and ABSL-4. A-only respondents may identify this item as not applicable. (3) Experience furnishing and managing qualified contractor resources for BSL-3 and BSL-4 laboratories and ABSL-3 and ABSL-4 environments. Identify specialties, numbers of contractor personnel supporting performance, and relevant performance examples. If comparable experience is unavailable, identify other evidence supporting the proposed capability. Explain how training, competency, occupational health, and access prerequisites are verified and coordinated with the receiving facility. Provide aggregate readiness information without medical records, sensitive laboratory security details, or unnecessary personal information. (4) The management and financial resources available to support the proposed workforce, including supervision, payroll, timekeeping, reporting, quality control, working capital, and transition continuity. Describe cost-reimbursement experience, accounting-system capabilities, any relevant Government reviews, and any preparation needed to support the anticipated cost-reimbursement component. This information is requested for market research and is not a mandatory qualification for responding. (5) The professional qualifications and relevant experience of the respondent's proposed key personnel. Respondents should identify their own key personnel appropriate to managing STEAM and provide resumes reflecting education, relevant work, proposed responsibilities, availability, and competing commitments. NIH is not prescribing a fixed key-personnel roster or a mandatory Principal Investigator position for this notice. Resumes are not required for every potential contractor personnel assignment. (6) The proposed prime, joint venture, and subcontractor roles, including the task areas and assigned categories, expected work shares, commitment status, and the prime’s management responsibilities. Identify the ability to meet applicable small-business eligibility and performance requirements if a set-aside is selected. Explain how the proposed performance arrangement provides coverage for every labor category within each task area addressed and, for Task Area B, all identified BSL and ABSL levels. Individual team members may provide portions of the required capability, but the proposed arrangement must collectively demonstrate full coverage for the respondent to be considered capable of supporting the applicable task area. Clearly identify gaps in full-scope coverage and any discrete portions that could be supported separately. Capability limited to discrete portions is insufficient to be considered capable of supporting the full task area. (7) Quantified annual and concurrent capacity. Respondents must provide numerical capacity estimates for each task area addressed, with assumptions and supporting evidence. Report task orders (TOs) and contractor personnel assignments separately: a task order may require multiple personnel, and the two measures must not be treated as interchangeable. For these capacity questions, a personnel assignment means one role filled by contractor personnel to perform an order’s SOW; it is a workload measure, not a separate task order or a Government hiring action. (a) Annual capacity: State the maximum number of new task orders the company could accept and perform in a 12-month period, and the maximum total number of task orders it could perform during that period, including orders continuing from prior periods. Separately state the number of new contractor personnel assignments it could mobilize during that period and its capacity to replace personnel while maintaining performance. Distinguish unique assignments from successive replacements in the same role. (b) Concurrent capacity: State the maximum number of active task orders and contractor personnel assignments the company could sustain at the same time. Explain the assumed number and mix of personnel assignments per order, order duration, geographic coverage, and constraints. For Task Area B, address constraints for specialized scientific assignments and BSL/ABSL assignments at each of the required BSL-1 through BSL-4 and ABSL-1 through ABSL-4 levels. (c) Available and surge capacity: Account for existing customer commitments and distinguish capacity currently available to NIH from capacity requiring additional hiring, financing, or team members. State the additional task orders and contractor personnel assignments that could be supported during a surge, the time needed to reach that level, and how long it could be sustained. For a response covering both areas, provide a combined achievable total and explain shared resources without double counting. (d) Supporting evidence: Provide actual annual task-order and personnel mobilization volumes and peak concurrent orders and contractor personnel assignments from comparable work within the last five years, identifying the period measured. Cross-reference examples under item (1) to avoid repetition. Distinguish demonstrated performance from projected capacity, explain how estimates were developed, and identify the capacity supplied by the company itself versus proposed joint-venture partners or subcontractors. If comparable history is unavailable, provide other evidence supporting the estimates. Explain the recruiting, management, and financial resources needed to sustain the stated volume. (8) Sources Sought Question. How would your firm fund uninterrupted performance during a surge in workload and a cash-flow stress period of up to 90 days between incurring costs and receiving payment? Briefly identify available or obtainable financing, existing obligations, and mitigation of any shortfall. This information is for market research, not an eligibility determination. Financial Review Statement. The Government intends to examine liquidity, working capital, financing availability, existing obligations, and surge and cash-flow contingency plans against solicitation-specific performance needs. Reasonable alternative evidence of financial capability, including resources obtainable by award, will be considered. Financial capability will be assessed as a responsibility matter in any resulting solicitation and award. The 90-day period is a market-research stress scenario, not a proposed payment term. No binding price proposal is requested. Information Submission Instructions: Page Limitations Capability statements must not exceed five (5) pages per task area, excluding key-personnel resumes. A respondent addressing both areas may submit up to ten (10) narrative pages combined, with separate A and B sections limited to five pages each. Cover pages, business information, tables, and project examples count toward these limits; common business information may be provided once and counted within one area’s limit. Use 10-to-12-point font, at least one-inch margins, and standard letter-size paper (8.5 x 11 inches), with no more than six lines of text per vertical inch. Resumes should be limited to two pages per key person. Internet links may not substitute for requested evidence. Mark proprietary information. Required Business Information: • Unique Entity ID (UEI) and CAGE code, if available. • Company name and physical address. • Technical and administrative points of contact, including names, titles, telephone numbers, and email addresses. • Small-business status under the proposed NAICS code, applicable socioeconomic designations and certification status, and SAM.gov registration status. • Cost-reimbursement capability and accounting-system review status, including the reviewing agency and date, if applicable. An existing Government approval is not required to respond. Number of Copies: Submit one (1) electronic copy of the capability statement and key-personnel resumes in searchable Adobe Portable Document Format (PDF), by email to both contracting contacts listed below. The email subject line must specify sources sought reference number 75N98027R00012 and the company name. The response must identify Task Area A, Task Area B, or both in its cover information and email subject. NIH will post notice amendments and updates on SAM.gov. Common Cut-off Date: Electronically submitted capability statements are due no later than November 16, 2026, at 11:59 p.m. Eastern Standard Time (EST). The Government may issue consolidated responses by amendment. An extension request or pending question does not change the response deadline; only a written Government amendment can do so. Respondents should not assume an extension will be granted. All responses must be received by the stated deadline to be assured consideration. Respondents that previously submitted a capability statement may submit a revised statement addressing these amended requirements. Any revised statement must be clearly identified as revised and must comply with the notice’s existing page limits and submission instructions. The Government will assess capability statements against the requirements of the notice as amended. Revised capability statements must be received by that deadline to be assured consideration. Except as expressly revised by this amendment, all other provisions of the Sources Sought Notice remain unchanged. This remains a sources sought notice for market research and is not a solicitation for proposals, proposal abstracts, or quotations. Disclaimer and Important Notes This notice does not obligate the Government to issue a solicitation, award a contract or order, or pay for information provided in response. Responses must be complete and sufficiently detailed to permit assessment of the respondent's capabilities. The Government may request clarification or verify references but is under no obligation to acknowledge receipt or provide individual feedback. Any subsequent solicitation will contain the governing requirements and instructions. A response to this notice will not substitute for a response to a solicitation. Confidentiality Clearly identify proprietary information. Information will be handled in accordance with applicable law. Do not submit classified information, sensitive laboratory security information, medical records, or unnecessary personal information. Identify supporting records requiring a Government-approved secure channel rather than attaching them to ordinary email. Contracting Office Address Department of Health and Human Services National Institutes of Health Division of Strategic Sourcing Office of Logistics and Acquisition Operations (OLAO) NIH Office of Acquisition and Logistics Management (OALM) 6701B Rockledge Drive Bethesda, Maryland 20817 Points of Contact: Kishan Patel, Contracting Officer Email: kishan.patel@nih.gov Alternate contact: Som Bahrami, Contracting Officer Email: som.bahrami@nih.gov
-Market Research11/16/2026
This is not a solicitation announcement. This is a Sources Sought Notice (SSN) only. This SSN is issued solely for market research and planning purposes – it does not constitute a Request for Proposal (RFP) or a promise to issue an RFP in the future. Further, the SSN does not commit the Government to contract for any supply or service whatsoever. The FDA is not seeking proposals and will not accept any unsolicited proposals. Responders are advised that the U.S. Government will not pay for any information or administrative costs incurred in response to this SSN; all costs associated with responding to this SSN will be solely at the expense of the interested respondents. Not responding to this SSN does not preclude participation in any future RFP, if issued. The purpose of this sources sought synopsis is to gain knowledge of potential qualified vendors to include potential 8(a) vendors 8(a) relative to the North American Industry Classification System (NAICS) code and capable of providing multidisciplinary scientific and regulatory professional services in support of FDA Centers and Offices. Responses to this Sources Sought Notice will be used by the Government to make appropriate determinations about potential sources. Project Title: FDA Scientific and Regulatory Support Services (SRS) IDIQ Background/Overview: The Food and Drug Administration (FDA) is a science-based regulatory agency critically important to the stability of the nation's public health and health care systems. FDA protects and promotes the health and safety of all Americans by enhancing the availability of safe medical products, foods, and animal products, and by promoting innovation that addresses unmet medical and public health needs. FDA decisions must be based on the best available scientific data and employ the best tools and methods available to ensure products meet the highest quality standards, while fostering innovation in the products it regulates. In support of its regulatory mission, FDA conducts scientific research across a broad range of disciplines including vaccines, drug safety, food safety, medical devices, biologics, toxicology, radiological products, and more. FDA's science is increasingly data-centric, complex, and collaborative, involving multidisciplinary groups across its Centers and Offices. Within the Center for Drug Evaluation and Research (CDER), the Office of Computational Science (OCS), established under the Office of Translational Sciences, supports the data management, technical, and analytic needs of the regulatory review process. OCS manages and supports analytical tools, data standards, and computing infrastructure that form the backbone of modern regulatory review for medical products. Purpose: The FDA is seeking information from experienced sources in Scientific and Regulatory Support Services as it is contemplating the establishment of a Indefinite Delivery Indefinite Quantity (IDIQ) to such services. The FDA’s primary objective for this effect is to obtain Contractor services related to scientific and regulatory support across a broad range of mission requirements. Depending on the requirement, services may support scientific research, regulatory review, clinical and non-clinical analyses, epidemiology and surveillance, scientific data interpretation, laboratory activities, technical writing, training, and scientific program coordination. Objectives: The objective of the contemplated SRS acquisition is to provide FDA with responsive, high-quality scientific and regulatory support across a broad range of mission requirements. Depending on the task order, services may support scientific research, regulatory review, clinical and nonclinical analyses, epidemiology and surveillance, scientific data interpretation, laboratory activities, technical writing, training, and scientific program coordination. The Government is interested in sources capable of providing the scientific depth and operational capacity needed to: Conduct scientifically sound analyses and prepare defensible, traceable technical products supporting FDA review and public-health decisions. Provide qualified personnel across multiple scientific and regulatory disciplines, including specialized and emerging areas. Support clinical and nonclinical study-data review, standardized scientific datasets, statistical computing, data fitness, quality assessment, and interpretation. Respond to multiple simultaneous task orders, changing priorities, time-sensitive scientific questions, and evolving requirements across FDA organizations. Maintain scientific quality, data integrity, documentation, confidentiality, and continuity of performance. Deliver effective scientific training, technical writing, knowledge transfer, and program-management support tied directly to scientific and regulatory missions. Project Requirements: The following descriptions are illustrative of the types of services that may be ordered. They are provided to inform industry responses and do not establish final task-order requirements. Each task order would define its own objectives, tasks, deliverables, performance expectations, staffing qualifications, and period of performance. Scientific Research and Regulatory Review Support: Support scientific investigations, literature and evidence reviews, research planning, study design, methodological assessments, scientific consultations, and technical analyses relevant to FDA-regulated products. Prepare scientific assessments, briefing materials, review support documentation, and other products that allow Government scientists and reviewers to evaluate scientific evidence and communicate findings. Provide subject-matter expertise to address complex or emerging regulatory science questions. Clinical and Nonclinical Study-Data Review and Analysis: Support the scientific review of clinical and nonclinical datasets submitted for regulatory purposes, including data fitness and completeness assessments, exploratory safety analyses, descriptive and inferential statistical analyses, and preparation of tables, listings, figures, and visualizations. Experience with standards such as CDISC SDTM, ADaM, and SEND may be relevant. The RRS BPA describes review-oriented services that assess study data and produce analyses for FDA reviewers; SRS would focus on the scientific and analytical performance of those services rather than maintenance of the underlying software platforms. Epidemiology, Biostatistics, Pharmacovigilance, and Surveillance: Conduct epidemiological and Pharmacoepidemiological research, biostatistical analyses, pharmacovigilance assessments, signal detection and evaluation, public-health surveillance, and interpretation of real-world data and evidence as required by individual scientific programs. Activities may include protocol and analysis-plan support, assessment of study limitations and bias, statistical programming, results interpretation, and technical reporting. Scientific Data Standards, Quality, and Analytics: Provide scientific expertise related to data standards, controlled terminology, study-data interpretation, data quality and fitness, and reproducible analytical methods. Support scientific data preparation and validation, biostatistics, bioinformatics, computational science, and other specialized analyses when the primary deliverable is scientific or regulatory in nature. Distinguish these activities from enterprise database administration, application development, platform engineering, and IT operations. Laboratory and Specialized Scientific Support: Provide laboratory-related scientific and technical expertise, research assistance, analytical method support, study coordination, quality documentation, and interpretation or reporting of laboratory findings where required by a task order. Respondents should identify the specific laboratory disciplines, facilities, qualifications, and methods they can support rather than assume that all clinical trial operations or laboratory testing will be included. Scientific Writing, Training, Knowledge Management, and Communications: Develop scientific reports, regulatory review support materials, technical summaries, study documentation, research publications, presentations, training curricula, and knowledge-transfer materials. Provide specialized scientific and regulatory training, including instruction related to study-data standards and analytical methods. Communications and knowledge-management work should be directly connected to scientific or regulatory activities rather than general enterprise communications or IT support. Scientific Program and Project Management: Plan and coordinate scientific studies and projects; manage milestones, deliverables, schedules, staffing, and technical reporting; facilitate multidisciplinary collaboration; track performance and quality; and support continuity during transitions. Such activities must be integral to scientific and regulatory service delivery, not standalone enterprise IT project management. Scope Distinctions: The contemplated SRS acquisition is not intended to replace vehicles for enterprise IT architecture, systems or application development, cloud or data-platform operations, infrastructure administration, software maintenance, generalized service-desk support, or other predominantly IT functions. Where a task combines scientific analysis and enabling technology, the Government will determine the appropriate vehicle and scope based on the primary purpose of the requirement. The final boundary between SRS and remaining RRS or other vehicles is subject to FDA and OAGS confirmation. Capabilities and Technical Experience: Interested small businesses should submit a concise capability statement demonstrating relevant, actual performance and capacity to satisfy the contemplated requirements. Responses should clearly distinguish capabilities performed by the respondent from those provided by subcontractors, affiliates, or proposed teaming partners. FDA is particularly interested in the following: Relevant Experience: Describe comparable scientific and regulatory engagements, customer organizations, contract or order identifiers where releasable, approximate value, period of performance, work performed, disciplines supported, and measurable outcomes. Explain how the experience relates to the breadth and complexity of the contemplated SRS work. Scientific and Regulatory Disciplines: Describe the service areas the respondent can perform, with concrete examples involving scientific research, regulatory analysis, clinical/nonclinical datasets, statistical methods, epidemiology, laboratory work, scientific writing, and training as applicable. Do not claim disciplines for which experience cannot be substantiated. Workforce and Concurrent Delivery Capacity: Describe the organization's demonstrated ability to recruit, retain, and deploy highly specialized scientific and regulatory professionals across a broad range of disciplines, including individuals with advanced degrees, niche technical expertise, and experience supporting complex scientific and regulatory programs. FDA recognizes that certain highly specialized skill sets may require recruitment from an international talent pool, including individuals holding or requiring employment-based visa sponsorship (e.g., H-1B) or other appropriate work authorization. Respondents should describe their experience recruiting and retaining such personnel, managing applicable sponsorship and work authorization requirements, and mitigating potential staffing disruptions during contract transitions. Responses should also address the organization's ability to fill hard-to-recruit positions, maintain continuity of specialized expertise, accommodate surge requirements, and support multiple concurrent task orders. Scientific Quality and Data Practices: Describe scientific quality-control procedures, independent review, data integrity and reproducibility practices, use of applicable scientific standards, confidentiality controls, and experience handling sensitive regulatory or research information. Representative Complex Requirement: Describe one or more specific scientific or regulatory assignments presenting substantial technical complexity, urgent timelines, or multidisciplinary coordination. Explain the challenge, approach, expertise, deliverables, and outcomes. Teaming and Prime-Contractor Role: Describe anticipated prime, subcontracting, joint-venture, or teaming arrangements and the work each participant would perform. Explain how the prime would exercise management and technical oversight while meeting applicable small-business requirements. Contract Structure Feedback: Identify whether the firm could support the full breadth of contemplated services or a defined subset and explain why. Instructions for Responses: Your responses to the questions provided below will assist the Government in selecting the appropriate acquisition method. Page limit: Maximum 15 pages (font size Times New Roman 11 or larger). A copy of the company capability statement will also be accepted (but not in place of the responses to the below questions). The anticipated period of performance is a 5-year ordering period. After review of the responses received, a pre-solicitation synopsis and formal solicitation may be published on SAM.gov. In addition to responses to the below questions, each vendor responding to this SSN shall also fill out and provide responses to “Attachment B-Vendor Feedback Form.” The Vendor Feedback Form is not included in the 15-page limit. A copy of the company capability statement will also be accepted (but not in place of the responses to the below questions or the Vendor Feedback Form). Responses to this notice must include company name, address, point of contact, size of business pursuant to the NAICS code, and must respond to the following questions: Is your business a small business under the NAICS code? Is your firm certified under Section 8(a) of the Small Business Act? Included is a draft Statement of Work that is inclusive of the anticipated Task Areas (Attachment A). All interested parties can provide written opinions on the draft Statement of Work. All opinions expressed should focus on strengthening the draft Statement of Work Tasks to ensure industry understands and comprehends the government’s requirements. Business Status Provide the legal business name and address Primary point of contact and the contact information SAM.gov Unique Entity Identifier (UEI) CAGE code Proposed NAICS code and size status Applicable small-business socioeconomic designations (including 8(a), HUBZone, service-disabled veteran-owned, veteran-owned, women-owned, or small disadvantaged business, as applicable) Identify whether the respondent proposes to participate as prime contractor, joint venture, or subcontractor Responses to this notice shall be submitted via e-mail to Amanda Edger, Contract Specialist, at Amanda.Edger@fda.hhs.gov (with a CC: to Ian Weiss, Contracting Officer, at Ian.Weiss@fda.hhs.gov), by November 23, 2026, at 2:00 pm EST. After a review of the received responses, a pre-solicitation synopsis and formal solicitation may be published on SAM.gov. No solicitation is currently available. This is not a request for proposals and in no way obligates the Government to award any contract. Responses to this Sources Sought Notice will not be considered adequate responses to the solicitation, a request to be added to a prospective offerors list, or a request to receive a copy of the solicitation. Ref. No. FDA-RFI-75F40127R00007/ALP No. OMITS-2027-136942.
-Market Research11/23/2026
-AwardedOpen
Synopsis: This is a Small Business Sources Sought notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding: (1) the availability and capability of qualified small business sources to perform a potential requirement; (2) whether they are small businesses; 8(a) small businesses, service-disabled veteran-owned small businesses; veteran-owned small businesses; women-owned small businesses; HUBZone small businesses; or small disadvantaged businesses; and (3) their size classification relative to the North American Industry Classification system (NAICS) code for the potential acquisition. Your responses to the information requested will assist the government in determining the appropriate acquisition method, including whether a small business set aside is possible. An organization that is not considered a small business under the applicable NAICS code should not submit a response to this notice. The requirement is assigned a code of 541715 in the North American Industry Classification System (NAICS), and the small business size standard for such requirements is 1,000 employees or less. This notice is issued for market research purposes to assess potential small business sources, industry practices, and the availability of commercial services. The Government has not made a final determination regarding acquisition strategy, contract type, commerciality, or small business set-aside status. Respondents should identify whether they can perform the requirement as a prime contractor, including through existing teaming arrangements or qualified subcontractors, and distinguish their own capabilities from those of proposed team members. Background: The National Institute on Minority Health and Health Disparities (NIMHD) conducts and supports research and training programs to advance knowledge and understanding of health disparities, identify mechanisms to improve minority health and reduce health disparities, and develop effective interventions in community and clinical settings. NIMHD is the lead organization at the National Institutes of Health (NIH) for planning, reviewing, coordinating, and evaluating minority health and health disparities research activities. NIMHD also promotes workforce development, supports research capacity at less-resourced institutions that train students in research careers, serves populations experiencing health disparities, supports participation in clinical research, and promotes information dissemination through regular communications, public education outreach, and scientific presentations. The President’s Executive Order (EO) 14212 Establishing the President’s Make America Healthy Again Commission aims to improve the health of Americans. As described in the EO, escalating burden of chronic diseases poses significant challenges in the United States. These conditions contribute to rising health costs, reduced workforce productivity, and stagnant life expectancies across the country, both in adults and children. NIH defines a health disparity as a measurable difference in health that exists between specific population groups. This is a rigorously derived and data-driven determination operationalized by quantifiable metrics, rather than a statement of attribution. It is a scientific starting point that identifies where health outcomes diverge, not a predetermined conclusion about why. Scientific investigations to identify or understand the root causes are separate and distinct scientific questions, which are necessarily multifaceted and complex. NIH funded research is interested in those health disparities that are modifiable or actionable to improve the health of all population groups. Health disparities may be observed in the risks, prevalence, or problems resulting from specific behaviors, as well as the incidence, prevalence, and mortality from conditions, diseases, and/or disorders. To fulfill the NIH mission of seeking fundamental knowledge about the nature and behaviors of individuals as living systems, and the statutory purpose of NIMHD, to conduct research to understand and reduce health disparities, NIMHD Division of Intramural Research (DIR) conducts population health research to understand how health outcomes vary across populations, identify multilevel modifiable factors that drive these disparities, and develop, test, and evaluate clinical and population-based interventions to reduce these disparities. NIMHD DIR requires contractor assistance to provide R&D social and behavioral sciences research services to support NIMHD DIR in conducting population health and clinical research to understand and reduce health disparities in the United States. The Government anticipates that individual task orders may involve differing research designs, study populations, sites, durations, and levels of complexity. Interested firms should explain their ability to mobilize qualified personnel and research resources for multiple concurrent studies as requirements arise. NIMHD is seeking small businesses capable of designing, conducting and overseeing the clinical, scientific, and technical aspects of investigations into health disparities across populations, to identify modifiable risk and protective factors associated with these disparities, and develop and test interventions to reduce these disparities. Study designs to be used may include, but are not limited to: Population-based cross-sectional surveys; Epidemiological studies (e.g., longitudinal cohort study, case-control studies); Clinical trials; Community-based intervention studies; Simulation modeling; and Qualitative research methods (e.g., direct observations, in-depth interviews, focus groups discussions). Independently and not as an agent of the Government, the Contractor shall furnish all necessary services, qualified personnel, material, equipment, and facilities not otherwise provided by the Government to successfully perform the requirements stated below. Specifically, the Contractor shall, as required by individual task orders, perform the following technical requirements summarized below that also are included in the attached Draft Statement of Work (SOW), including but not limited to: Provide personnel, facilities, and other services necessary to maintain and coordinate multiple health disparities research studies funded through task orders under this Indefinite Delivery, Indefinite Quantity (IDIQ) contract. Provide overall project management and coordination of activities performed under individual task orders, including development and maintenance of project plans, schedules, milestones, coordination of participating research sites and subcontractors, monitoring of performance, identification and resolution of project risks and issues, and preparation of progress reports as specified in the applicable task order. Conduct research studies through qualified organizations, as specified in individual task orders, and receiving consent from the Contracting Officer’s Representative (COR) and Contracting Officer (CO). This includes (but is not limited to) implementation of protocols; population health and clinical research site monitoring; regulatory compliance assurance; and analyses of data from clinical, laboratory, population and epidemiologic studies. Provide and manage participating population health research and clinical trial sites, investigators, laboratories, and other research resources necessary to conduct studies, directly or through qualified subcontractors. The Contractor shall draft, negotiate, execute, administer, monitor, renew and/or modify as necessary, subject to subcontractor's satisfactory past performance, and with the consent of the CO, subcontracts with domestic population health studies, clinical research sites and laboratories, and provide support for these population health studies, clinical research site and laboratories. The Contractor shall assume responsibility for population health and clinical sites, including site readiness to start new research studies. This includes the establishment of new subcontract agreements for these sites (including laboratories), data management, and other operations and functions. As existing protocols close, the Contractor shall assume responsibility for any new protocols at these sites. Recruit and retain numbers of potential research subjects sufficient for the timely completion of all protocols. Provide United States based investigators in the United States with expertise in the population health and clinical care, to conduct protocols specified through individual task orders. Provide professional and technical staff adequate to provide scientific and administrative coordination of multiple population health and clinical health disparities research studies. These staff shall include, but are not limited to, qualified medical, nursing, and neuropsychologic staff, study coordinators, personnel for participant identification, recruitment, study conduct, and retention, pharmacists, and laboratory technicians. Ensure sites have access to populations of interest, laboratory facilities with the capability to perform clinical research specified in task orders. Identify and engage community organizations, community leaders, health care providers, and other relevant stakeholders; establish and support community advisory boards, community coalitions, or other partnerships; conduct community needs and readiness assessments; and facilitate community participation in research planning, implementation, and dissemination of findings. Develop and implement quantitative and qualitative data collection methods, including surveys, interviews, focus groups, direct observations, and other methods appropriate to the research protocol. The Contractor shall manage, analyze, and report data collected through these methods, as required by individual task orders. Provide facilities and equipment adequate to conduct population health, inpatient and outpatient clinical research studies. Equipment purchases must be approved by the COR and CO. Ensure that sites have (through lease or direct provision, if required) electronic information systems compliant with the Federal Information Security Modernization Act (FISMA), necessary specialized equipment (including hardware and software) for sites to electronically communicate with the Contractor, subcontractors, and NIMHD DIR as required, for processing and storage of biospecimens (e.g., ultralow temperature freezer, specialized shipping materials and training for shipment of biohazardous materials and dangerous goods, and for receipt, storage, monitoring, and dispensing of investigational drugs). Obtain access for research protocol review and approval (or exemption) to a standing Institutional Review Board (IRB) and ensure that each institution conducting population health and clinical research studies has a current, approved Federal-Wide Assurance Number on file with the Office for Human Research Protections (OHRP). Ensure that all the staff at each site participating in the design or conduct of population health and clinical research involving human subjects, complete and maintain education on the human research protections. Ensure that when appropriate, population health and clinical research sites have a community advisory board (CAB) constituted with members of the local community that can provide community perspective and advice for science in the community where the population health and clinical research is located and that provides community input. The Contractor shall provide services to ensure regulatory compliance for research activities including subcontracted sites' performance. More specifically: Ensure site access to a communications system in compliance with U.S. Food and Drug Administration (FDA) requirements for the submission of Adverse Experience Reports (AERs) by Subcontractors to the Contractor for transmission as required to the COR as required. Monitor the accuracy of adverse experience reporting through regular summary reports for submission to the COR. Draft safety reports as required by the FDA for selected studies for COR Submission. Develop, implement, and monitor plans for acquisition, distribution, dispensing, handling, administration, and accountability of study interventions (pharmaceutical and non-pharmaceutical), in compliance with applicable Federal, state, and local regulations. Provide site monitoring for quality assurance of research conducted at all clinical and laboratory sites, as designated by the COR. Monitoring schedules shall be approved by and results reported to the COR with a copy to the CO and shall include assurance of compliance with FDA record keeping and reporting requirements (21 CFR 50 and 56; 21 CFR 312.50, Subpart D), accuracy and completeness of case report forms, source documentation, and other research records, and periodic record auditing and documentation by the staff of the subcontracted centers. Each site shall be visited a minimum of 2-3 times annually. Provide staff with laboratory expertise and assist in monitoring clinical trials site laboratory quality with the COR and NIMHD Quality Assurance (QA) programs. Meet with the NIMHD program and contracting staff to review annual site performance and monitoring reports for participating population health and clinical research sites. The Contractor shall provide population health, clinical and statistical analysis and reports. More specifically: Provide scientific, technical, and administrative support for the development, implementation, and analysis of the specified research, including considerations of experimental design, sample size calculation, and interim and final primary and secondary analyses specified by study protocols, as requested by the COR. Establish data elements to be recorded by the protocol research records, as requested by the COR and in conjunction with the protocol development team for each specific research project. Develop study forms for standardized collection of data items. Develop documentation and coding for computerization of data for retrieval, analysis, and reporting. Provide for timely and accurate data collection and submission, data entry, data quality assurance, retrieval of source documentation, and generation of data and safety monitoring reports. Provide training for staff of population health, clinical and laboratory sites in data management procedures. Provide data input, editing, electronic data storage, database management, data retrieval, and statistical analysis using well-documented database management and statistical computer software programs. Develop methodology, perform analyses, and provide results from meta-analyses of selected data sets derived from population health and clinical research studies that focus on health disparities. Provide data analysis and results. More specifically: Perform statistical analyses of study data to test study hypotheses and evaluate potential confounding variables and/or covariates, as requested by the COR. Data analytic techniques needed include approaches to analyzing multiple measurements of biologic variables over time within participants and between participant groups, with consideration for normal changes in these variables with demographics. Provide for biweekly to monthly communication, as needed, of analytic progress and results through routine meetings (the majority to be virtually) with COR or designees and periodic generation of reports. The Project Manager shall attend all meetings. The Epidemiologist, Statistician, and Senior Systems Analyst shall attend these meetings on an as needed basis dependent upon the PI’s request. Provide programming and statistical support adequate for the timely generation of additional analyses requested by the COR. Provide electronic data transmission between the Contractor, population health, clinical and laboratory sites, and NIMHD DIR using currently specified communications software and equipment. Provide for electronic mail transmission between the Contractor, population health, clinical and laboratory sites, and NIMHD DIR using commercially available communications software and equipment. Provide protocol development services and assistance. The Contractor shall provide services for the implementation and monitoring of multiple population health and clinical research studies. More specifically: Develop, initiate and coordinate implementation and oversight of protocols at all participating population health, clinical and laboratory sites designed by the COR and approved by the CO. Ensure compliance by sites with all requirements for protocol implementation, including IRB review and approval prior to protocol initiation, participant consent, and confidentiality requirements, and Federal bioresearch regulations and requirements for security and confidentiality of research records, and that each relevant population health and clinical research site staff member completes and maintains human research protection and Good Clinical Practice training, when appropriate. Draft, negotiate, execute, administer, monitor, renew and/or modify as necessary with approval by CO a site-specific, protocol-specific budget for each protocol to be conducted by population health, clinical and laboratory sites, based on the anticipated number of participants to be enrolled. Provide training for staff of clinical and laboratory centers in procedures for implementation and conduct of specific protocols. Retraining may be required to be performed as necessary. Provide training in and ensure the fulfillment and maintenance of standards for Good Clinical Practices (GCP) and Good Clinical Laboratory Practices (GCLP) across population health and clinical research sites and staff, whenever appropriate. Ensure timely development and execution of material transfer agreements (MTAs) and data transfer agreements (DTAs) between the sponsor(s) and population health and clinical research sites. The Contractor shall provide services for the development and review of research activities. More specifically: For specific new protocol topics identified by the COR, identify a protocol development team consisting of Contractor staff, NIH staff, subcontractors, and/or consultants. Provide support for the planning and conduct of protocol development team meetings. Submit at the initial meeting a protocol development plan for COR review and approval, addressing regulatory issues, data collection forms development, drug distribution plan, protocol timeline, and participating sites. Develop a protocol document including background, objectives and endpoints, design, patient numbers, source, management, and selection, study agents or other interventions, clinical and laboratory monitoring, laboratory services, toxicity management, adverse experience reporting, evaluation of response, statistical considerations, data collection and monitoring, human subjects’ considerations, biohazard containment, and data and safety reviews. Review, edit, and rewrite draft protocols based on COR’s review. Prepare and maintain the necessary documentation for application submissions in compliance with FDA requirements. Upon completion of a final protocol, renegotiate subcontractor budgets with the approval of the CO and implement the new protocol at participating sites. For ongoing protocols, provide, at the request of the COR, support for the planning and conduct of meetings of protocol committees and subcommittees, data and safety monitoring boards, and investigators. Provide administrative, technical, and logistical support at the request of the COR and with approval of the CO as needed for interaction and collaboration of the Subcontractors with other institutes, agencies, and organizations conducting activities relevant to health disparities research. Support the identification, development, implementation, and evaluation of interventions to improve health outcomes and reduce health disparities, including assessment of feasibility, acceptability, effectiveness, and potential impact. Provide consultants with specialized expertise related to population health and clinical research especially related to health disparities, as requested by NIMHD DIR. Plan, organize, and coordinate meetings involving internal and outside experts. This meeting will be an important venue to discuss important and complex scientific issues related to research protocols and emerging research priorities. Provide support services for ongoing population health and clinical research studies, which include, but are not limited to, the following: site monitoring, subcontract management and invoicing, protocol management, oversight of data management and data analysis, study agent procurement, team meetings, regulatory compliance assurance, site activation and protocol registration, safety monitoring, committee management, data management services, oversight of central and site laboratories and pharmacies, protocol team support, FISMA compliance and IT security, laboratory equipment support, and training of site personnel, to support this effort. Provide Core infrastructure support for ongoing population health and clinical research at the sites, including but not limited to the following: maintenance of IRB/EC regulatory reporting, subject recruitment and follow-up, Community Advisory Board (CAB) support for meetings, protocol updates and reporting, attendance and participation in site monitoring visits, attendance at the annual network meeting, invoicing and other report preparation. Experience coordinating data from all aspects of ongoing protocols, studies, and trials. Experience in initiating and managing 3-6 studies each year. Experience initiating and managing studies of different sizes from approximately 100 participants up to approximately 10,000 participants. Experience working with populations experiencing health disparities, e.g., people in low socioeconomic conditions, living in rural underserved areas, and racial and/or ethnic populations who have documented health disparities based on diseases and conditions. Experience initiating and managing studies with a length in time from a few months for cross-sectional studies to a few years in clinical studies. Experience managing studies of varying complexities from simpler studies, which may be qualitative studies involving in-depth interviews with about 100 people; to more complex studies that involve a multi-site clinical trial with 1-2 years follow-up including biospecimen collection. Commercial Availability of Services – Based on preliminary market research, the Government anticipates that the contemplated research services may be noncommercial in nature. However, interested respondents are encouraged to identify comparable services available in the commercial marketplace. If so, describe which portions of the requirement could be met commercially and which would require customization, integration, or specialized development. Provide supporting information, including customary pricing practices and potential firm-fixed-price arrangements, if available. Industry Feedback on Draft SOW – Respondents are encouraged to provide comments or recommendations on the draft SOW, including opportunities to clarify requirements, improve performance outcomes, identify potential implementation challenges, or incorporate commercially available approaches. Identify any provisions that may unnecessarily limit small business participation and suggest practical alternatives. Any recommendations should identify the applicable SOW section when possible. Anticipated Award Date: The Government expects to award an Indefinite Delivery Indefinite Quantity (IDIQ) contract approximately in September 2027. Disclaimer and Important Notes: This notice does not obligate the government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization’s qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a presolicitation synopsis and solicitation may be published in SAM.gov. However, responses to this notice will not be considered adequate responses to a solicitation. No award will be made as a result of this notice. The Government will NOT be responsible for any costs incurred by the respondents to this Notice. This notice is for information purposes only. CONFIDENTIALITY: No proprietary, classified, confidential, or sensitive information should be included in your response. The government reserves the right to use any nonproprietary technical information in any resultant solicitation(s). Responses and Capability Statements: Interested Small Businesses that believe they possess the capabilities necessary to undertake this project should submit an electronic copy of their capability statement addressing the areas listed above to the attention of Edwin Osorio, Contract Specialist (E-mail: edwin.osorio@nih.gov) and Lisa Schaupp, Contracting Officer (E-mail: lisa.schaupp@nih.gov). Please state clearly in the subject line of the email that it is in response to the Sources Sought notice no.75N94027R00005. Please limit responses to 20 pages or less, exclusive of resumes. Electronic capability statements should be received by the Contracting Officer and Contract Specialist by 4:30 PM Eastern time on November 25, 2026. Respondents must submit their capability statement via electronic submission only. Capability statements must identify the 1) organization name, address, point of contact, contact phone number, and email address; 2) Small Business status of the organization, NAICS code along with SAM.gov Unique Entity Identifier (UEI) and CAGE code, if assigned, size and type of business (e.g., 8(a), HUBZone, etc.). No phone calls will be accepted. The designated NAICS code for this effort is 541715 and the size standard is 1,000 employees or less. Respondents may provide brief SOW comments and commercial availability information within the existing 20-page response limit. The Government may use the information received to refine the draft SOW and acquisition strategy; participation does not preclude responding to any future solicitation.
-Market Research11/25/2026

Additional Details

Solicitation Number

75N92023R0178

Archive Date

Apr 11, 2023

Office Address

BETHESDA, MD, 20892